ALXN News and Press, Alexion Pharmaceuticals Inc. From 09/03/20

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the following upcoming investor conferences: Citi’s 15 th Annual BioPharma Conference, taking place virtually on Thursday, September 10 th , 2020 at 10:45 a.m. ET. Morgan Stanley’s 1...

Alexion Pharmaceuticals ( ALXN +8.4% ) is up on more than 50% higher volume in reaction to Novartis' ( NVS -0.1% ) announcement of positive results from an open-label,  Phase 2 clinical trial evaluating investigational oral treatment LNP023 in patients with paroxysmal nocturnal h...

What a difference six months makes. Back in late February, Wall Street was just beginning to come to terms with the scary reality that the coronavirus disease 2019 (COVID-19) pandemic was going to levy an immense physical and financial toll on the United States. This resulted in five weeks of ut...

This article series shows every month a dashboard with aggregate industry metrics in healthcare (popular ETFs in this sector: XLV , IYH , IBB , XBI , VHT , XPH ). Shortcut If you are used to this dashboard series or if you are short on time, you can skip the first paragraphs and go...

This has been a year that Wall Street and investors won't soon forget. The coronavirus disease 2019 (COVID-19) pandemic has exacted an incredible physical and financial toll on this country, with more than 163,000 Americans losing their lives, over 20 million people (at one time) losing their jo...

If you were to look up the definition of "volatility" in the dictionary, don't be surprised if it made reference to the stock market in 2020. Based on the CBOE Volatility Index , the stock market has registered its most volatile year on record. Then again, if investors were to focus solely on ...

Biotech stocks are often prone to highly inflated or highly deflated prices stemming from hyped news cycles. Between difficult-to-interpret news about a company's clinical-trial results and the sheer length of the drug-development cycle, some stocks spend months languishing because of the market...

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the appointment of Uzair Qadeer as the company’s first Chief Diversity Officer. In this new role, Mr. Qadeer will be responsible for shaping the company’s diversity, inclusion and belonging (DI&B) strategy, buildi...

Stocks with strong insider buying can be a good indicator for future price appreciation. Here are four stocks in the S&P 500 with the highest recent positive insider transactions: Sysco Corporation (SYY), Alexion Pharmaceuticals (ALXN), TransDigm Group (TDG), and Newell Brands (NWL). In...

Image source: The Motley Fool. Alexion Pharmaceuticals   (NASDAQ: ALXN) Q2 2020 Earnings Call Jul 30, 2020 , 8:00 a.m. ET Operator Continue reading